PEPSIAMERICAS, INC. UNDERWRITING AGREEMENT
Exhibit 1.1
PEPSIAMERICAS, INC.
$350,000,000
4.375% Notes due 2014
February 9, ▇▇▇▇
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇ Securities LLC
▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
▇.▇. ▇▇▇▇▇▇ Securities Inc.
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
several Underwriters listed
in Schedule 1 hereto
Ladies and Gentlemen:
PepsiAmericas, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the
several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as
representative (collectively, the “Representative”), $350,000,000 aggregate principal amount of its
4.375% Notes due 2014 (the “Securities”). The Securities will be issued under an indenture, dated
as of August 15, 2003 (as amended or supplemented with respect to such Securities, the
“Indenture”), between the Company and ▇▇▇▇▇ Fargo Bank, National Association, as trustee (the
“Trustee”).
The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), an automatic
shelf registration statement on Form S-3 (File No. 333-134179), including a prospectus, relating to
the Securities. Such registration statement, as amended at the time it became effective, including
the information, if any, deemed pursuant to Rule 430B or 430C under the Securities Act to be part
of the registration statement at the time of its effectiveness (“Rule 430 Information”), is
referred to herein as the “Registration Statement”; and as used herein, the term “Preliminary
Prospectus” with reference to the Securities means each prospectus included in such registration
statement (and any amendments thereto) before it becomes effective, any prospectus filed with the
Commission pursuant to Rule 424(a) under the Securities Act, the prospectus included in the
Registration Statement at the time of its effectiveness that omits Rule 430 Information and any
prospectus supplement that omits final pricing terms that is filed with the Commission pursuant to
Rule 424(b) under the Securities Act; and the term “Prospectus” means the final prospectus and
prospectus supplement in the form first used (or made available upon request of purchasers pursuant
to Rule 173 under the Securities Act) in connection with sales of the Securities. Any reference in
this Agreement to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be
deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12
of Form S-3 under the Securities Act as of the effective date of the Registration Statement or the
date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to
“amend”, “amendment” or “supplement” with respect to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such
date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the
Commission thereunder (collectively, the “Exchange Act”) that are deemed to be incorporated by
reference therein. Capitalized
1
terms used but not defined herein shall have the meanings given to such terms in the
Registration Statement and the Prospectus.
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the
Company had prepared the following information (collectively, the “Time of Sale Information”): a
Preliminary Prospectus dated February 9, 2009, and each “free-writing prospectus” (as defined
pursuant to Rule 405 under the Securities Act) listed on Annex A hereto, including the final term
sheet relating to the Securities.
2. Purchase of the Securities by the Underwriters. The Company agrees to issue and
sell the Securities to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective principal amount of Securities set forth opposite such Underwriter’s name in
Schedule 1 hereto at a price equal to 98.769% of the principal amount thereof. The Company will not
be obligated to deliver any of the Securities except upon payment for all the Securities to be
purchased as provided herein.
Payment for and delivery of the Securities will be made at 10:00 A.M., New York City time, on
February 12, 2009, or at such other time or place on the same or such other date, not later than
the fifth business day thereafter, as the Representative and the Company may agree upon in writing.
The time and date of such payment and delivery is referred to herein as the “Closing Date”. Payment
for the Securities shall be made by wire transfer in immediately available funds to the account(s)
specified by the Company to the Representative against delivery to the nominee of The Depository
Trust Company, for the account of the Underwriters, of one global note representing the Securities
(the “Global Note”), with any transfer taxes payable in connection with the sale of the Securities
duly paid by the Company. The Global Note will be made available for inspection by the
Representative not later than 1:00 P.M., New York City time, on the business day prior to the
Closing Date.
The Company acknowledges and agrees that the Underwriters are acting solely in the capacity of
an arm’s length contractual counterparty to the Company with respect to the offering of Securities
contemplated hereby (including in connection with determining the terms of the offering) and not as
a financial advisor or a fiduciary to, or an agent of, the Company or any other person.
Additionally, neither the Representative nor any other Underwriter is advising the Company or any
other person as to any legal, tax, investment, accounting or regulatory matters in any
jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be
responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company
with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of
the Underwriters and shall not be on behalf of the Company.
3. Representations and Warranties of the Company. The Company represents and warrants
to each Underwriter that:
(a) Preliminary Prospectus. No order preventing or suspending the use of any Preliminary
Prospectus has been issued by the Commission, and each Preliminary Prospectus, at the time of
filing thereof, complied in all material respects with the Securities Act and did not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading; provided that the Company makes no representation and
warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representative expressly for use in any Preliminary Prospectus.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did not, and
at the Closing Date will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that the Company makes no representation and
warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representative expressly for use in such Time of Sale Information. No statement of
material fact included in the Prospectus has been omitted from the Time of Sale Information and no
2
statement of material fact included in the Time of Sale Information that is required to be
included in the Prospectus has been omitted therefrom.
(c) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the Prospectus,
the Company (including its agents and representatives, other than the Underwriters in their
capacity as such) has not made, used, prepared, authorized, approved or referred to and will not
prepare, make, use, authorize, approve or refer to any “written communication” (as defined in Rule
405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy
the Securities (each such communication by the Company or its agents and representatives (other
than a communication referred to in clause (i) below) an “Issuer Free Writing Prospectus”) other
than (i) any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the
Securities Act or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto
and other written communications approved in writing in advance by the Representative. Each such
Issuer Free Writing Prospectus did not and will not conflict with the information contained in the
Registration Statement, the Time of Sale Information or the Prospectus, complied in all material
respects with the Securities Act, has been filed in accordance with the Securities Act (to the
extent required thereby) and, when taken together with the Preliminary Prospectus filed prior to
the first use of such Issuer Free Writing Prospectus, did not, and at the Closing Date will not,
contain any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with respect to
any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and
in conformity with information relating to any Underwriter furnished to the Company in writing by
such Underwriter through the Representative expressly for use in any Issuer Free Writing
Prospectus.
(d) Registration Statement and Prospectus. The Registration Statement is an “automatic shelf
registration statement” as defined under Rule 405 of the Securities Act that has been filed with
the Commission not earlier than three years prior to the date hereof; and no notice of objection of
the Commission to the use of such registration statement or any post-effective amendment thereto
pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order
suspending the effectiveness of the Registration Statement has been issued by the Commission and no
proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or
related to the offering of the Securities has been initiated or threatened by the Commission; as of
the applicable effective date of the Registration Statement and any amendment thereto, the
Registration Statement and such amendment complied and will comply in all material respects with
the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules and regulations
of the Commission thereunder (collectively, the “Trust Indenture Act”), and neither the
Registration Statement nor any amendment thereto relating to the offering contemplated hereby
contained or will contain any untrue statement of a material fact or omitted or will omit to state
a material fact required to be stated therein or necessary in order to make the statements therein
not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as
of the Closing Date, the Prospectus and any amendment or supplement thereto complied and will
comply in all material respects with the Securities Act and the Trust Indenture Act, and neither
the Prospectus nor the Prospectus as amended or supplemented will contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with respect to
(i) that part of the Registration Statement that constitutes the Statement of Eligibility (Form
T-1) of the Trustee under the Trust Indenture Act or (ii) any statements or omissions made in
reliance upon and in conformity with information relating to any Underwriter furnished to the
Company in writing by such Underwriter through the Representative expressly for use in the
Registration Statement and any amendment thereto and the Prospectus and any amendment or supplement
thereto.
(e) Incorporated Documents. The documents incorporated by reference in the Registration
Statement, the Prospectus or the Time of Sale Information, when they were, are or will be filed
with the Commission, conformed in all material respects to the requirements of the Exchange Act,
and none of such documents contained or will contain any untrue statement of a material fact or
omitted or will omit to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; provided, however, that, as to future filings, such representation relates only to
those future filings made prior to the termination of the offering.
3
(f) Financial Statements. The financial statements and the related notes thereto included or
incorporated by reference in the Registration Statement, the Time of Sale Information and the
Prospectus comply in all material respects with the applicable requirements of the Securities Act
and the Exchange Act, as applicable, and present fairly the financial position of the Company and
its subsidiaries as of the dates indicated and the results of their operations and the changes in
their cash flows for the periods specified; such financial statements have been prepared in
conformity with generally accepted accounting principles applied on a consistent basis throughout
the periods covered thereby, and the supporting schedules included or incorporated by reference in
the Registration Statement present fairly the information required to be stated therein; and the
other financial information included or incorporated by reference in the Registration Statement,
the Time of Sale Information and the Prospectus has been derived from the accounting records of the
Company and its subsidiaries and presents fairly the information shown thereby.
(g) Disclosure Controls. The Company and its subsidiaries maintain an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is
designed to ensure that information required to be disclosed by the Company in reports that it
files or submits under the Exchange Act is recorded, processed, summarized and reported within the
time periods specified in the Commission’s rules and forms, including controls and procedures
designed to ensure that such information is accumulated and communicated to the Company’s
management as appropriate to allow timely decisions regarding required disclosure. The Company and
its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and
procedures as required by Rule 13a-15 of the Exchange Act.
(h) Accounting Controls. The Company and its subsidiaries maintain systems of “internal
control over financial reporting” (as defined in Rule 13a-15(f) of the Exchange Act) that comply
with the requirements of the Exchange Act and have been designed by, or under the supervision of,
their respective principal executive and principal financial officers, or persons performing
similar functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles, including, but not limited to policies and procedures that: (i)
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the Company
are being made only in accordance with authorizations of management and directors of the Company;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use or disposition of the Company’s assets that could have a material effect on the
financial statements. Except as disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, there are no material weaknesses in the Company’s internal
controls.
(i) ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. There is and has been no failure on the part of the Company or any of
the Company’s directors or officers, in their capacities as such, to comply with any provision of
the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act of 2002 and the rules and regulations promulgated in connection therewith
(the “▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act”), including Section 402 related to loans and Sections 302 and 906 related
to certifications.
(j) Status under the Securities Act. The Company is not an ineligible issuer and is a
well-known seasoned issuer, in each case as defined under the Securities Act, in each case at the
times specified in the Securities Act in connection with the offering of the Securities. The
Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the
Securities Act or will pay such fees within the time period required by such rule (without giving
effect to the proviso therein) and in any event prior to the Closing Date.
4. Further Agreements of the Company. The Company covenants and agrees with each
Underwriter that:
(a) Required Filings. The Company will file the Preliminary Prospectus and the final
Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430B or
430C under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required
by Rule 433 under the Securities Act, including the final term sheet relating to the Securities;
and will file promptly all reports and any definitive proxy or information statements required to
be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a
4
prospectus is required (or but for the exemption in Rule 172 under the Securities Act would be
required to be delivered) in connection with the offering or sale of the Securities; and the
Company will furnish copies of the Preliminary Prospectus and the Prospectus and each Issuer Free
Writing Prospectus (to the extent not previously delivered) to the Underwriters in New York City
prior to 10:00 A.M., New York City time, on the second business day next succeeding the date of
this Agreement in such quantities as the Representative may reasonably request. The Company will
pay the registration fees for the offering of the Securities within the time period required by
Rule 456(b)(1) under the Securities Act prior to the Closing Date.
(b) Delivery of Copies. The Company will deliver, without charge, (i) to the Representative,
two signed copies (or photostatic reproductions of such signed copies) of the Registration
Statement as originally filed and each amendment thereto, in each case including all exhibits and
consents filed therewith and documents incorporated by reference therein and (ii) to each
Underwriter (A) a conformed copy of the Registration Statement as originally filed and each
amendment thereto, in each case including all exhibits and consents filed therewith and (B) during
the Prospectus Delivery Period (as defined below), as many copies of the Preliminary Prospectus and
the Prospectus (including all amendments and supplements thereto and documents incorporated by
reference therein) and each Issuer Free Writing Prospectus as the Representative may reasonably
request. As used herein, the term “Prospectus Delivery Period” means such period of time after the
first date of the public offering of the Securities as in the opinion of counsel for the
Underwriters a prospectus relating to the Securities is required by law to be delivered (or would
required to be delivered but for the exemption in Rule 172 under the Securities Act) in connection
with sales of the Securities by any Underwriter or dealer.
(c) Amendments or Supplements; Issuer Free Writing Prospectuses. Before preparing, using,
authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before
filing any amendment or supplement to the Registration Statement or the Prospectus relating to the
offering contemplated hereby, the Company will furnish to the Representative and counsel for the
Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement, as the
case may be, for review and will not prepare, use, authorize, approve, refer to or file any such
Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the
Representative reasonably objects.
(d) Notice to the Representative. With respect to the offering contemplated hereby, the
Company will advise the Representative promptly, and confirm such advice in writing, (i) when any
amendment to the Registration Statement has been filed or becomes effective; (ii) when any
supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing
Prospectus has been filed; (iii) of any request by the Commission for any amendment to the
Registration Statement or any amendment or supplement to the Prospectus or the receipt of any
comments from the Commission relating to the Registration Statement or any other request by the
Commission for any additional information; (iv) of the issuance by the Commission of any order
suspending the effectiveness of the Registration Statement or preventing or suspending the use of
any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for
that purpose or pursuant to Section 8A of the Securities Act; (v) of the occurrence of any event
within the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale
Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any
untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances existing
when the Prospectus, the Time of Sale Information or any such Issuer Free Writing Prospectus is
delivered or made available to a purchaser, not misleading; (vi) of the receipt by the Company of
any notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (vii) of
the receipt by the Company of any notice with respect to any suspension of the qualification of the
Securities for offer and sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing
or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such
qualification of the Securities and, if any such order is issued, will use its reasonable best
efforts to obtain as soon as possible the withdrawal thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event shall occur
or condition shall exist as a result of which the Prospectus as then amended or supplemented would
include any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the
circumstances existing when the Prospectus is delivered or made
5
available to a purchaser, not misleading or (ii) it is necessary to amend or supplement the
Prospectus to comply with law, the Company will immediately notify the Underwriters thereof and
forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the
Underwriters and to such dealers as the Representative may designate, such amendments or
supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so
amended or supplemented will not, in the light of the circumstances existing when the Prospectus is
delivered or made available to a purchaser, be misleading or so that the Prospectus will comply
with law and (2) if at any time prior to the Closing Date (i) any event shall occur or condition
shall exist as a result of which the Time of Sale Information as then amended or supplemented would
include any untrue statement of a material fact or omit to state any material fact necessary in
order to make the statements therein, in the light of the circumstances, not misleading or (ii) it
is necessary to amend or supplement the Time of Sale Information to comply with law, the Company
will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(c) above, file with the Commission (to the extent required) and furnish to the Underwriters and to
such dealers as the Representative may designate, such amendments or supplements to the Time of
Sale Information as may be necessary so that the statements in the Time of Sale Information as so
amended or supplemented will not, in the light of the circumstances, be misleading or so that the
Time of Sale Information will comply with law.
(f) Blue Sky Compliance. The Company will qualify the Securities for offer and sale under the
securities or Blue Sky laws of such jurisdictions as the Representative shall reasonably request
and will continue such qualifications in effect so long as required for distribution of the
Securities; provided that the Company shall not be required to (i) qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would
not otherwise be required to so qualify, (ii) file any general consent to service of process in any
such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not
otherwise so subject.
(g) Earning Statement. The Company will make generally available to its security holders and
the Representative as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring
after the “effective date” (as defined in Rule 158) of the Registration Statement.
(h) Expenses. The Company will pay all expenses incident to the performance of its obligations
under this Agreement and will reimburse the Underwriters for any expenses (including fees and
disbursements of counsel) incurred by them in connection with qualification of the Securities for
sale under the laws of such jurisdictions as the Representative may reasonably designate and the
printing of memoranda relating thereto, for any fees charged by investment rating agencies for the
rating of the Securities and for expenses incurred in distributing the Preliminary Prospectus, the
Prospectus and any Issuer Free Writing Prospectus (and any amendment or supplement thereto) to the
Underwriters.
(i) Clear Market. During the period from the date hereof through and including the business
day following the Closing Date, the Company will not, without the prior written consent of the
Representative, offer, sell, contract to sell or otherwise dispose of any debt securities issued or
guaranteed by the Company and having a tenor of more than one year.
(j) Record Retention. The Company will, pursuant to reasonable procedures developed in good
faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission
in accordance with Rule 433 under the Securities Act.
(k) Use of Proceeds. The Company will apply the net proceeds from the sale of the Securities
as described in the Registration Statement, the Time of Sale Information and the Prospectus under
the heading “Use of Proceeds.”
(l) Registration Statement Renewal Deadline. If immediately prior to the third anniversary
(the “Renewal Deadline”) of the initial effective date of the Registration Statement, any of the
Securities remain unsold by the Underwriters, the Company will prior to the Renewal Deadline file,
if it has not already done so and is eligible to do so, a new automatic shelf registration
statement relating to the Securities, in a form satisfactory to the Representative. If the Company
is no longer eligible to file an automatic shelf registration statement, the Company will prior to
the Renewal Deadline, if it has not already done so, file a new shelf registration statement
relating to the
6
Securities, in a form satisfactory to the Representative, and will use its best efforts to
cause such registration statement to be declared effective within 60 days after the Renewal
Deadline. The Company will take all other action necessary or appropriate to permit the public
offering and sale of the Securities to continue as contemplated in the expired registration
statement relating to the Securities. References herein to the Registration Statement shall include
such new automatic shelf registration statement or such new shelf registration statement, as the
case may be.
(m) Notice of Inability to Use Automatic Shelf Registration Statement Form. If at any time
when Securities remain unsold by the Underwriters the Company receives from the Commission a notice
pursuant to Rule 401(g)(2) or otherwise ceases to be eligible to use the automatic shelf
registration statement form, the Company will (i) promptly notify the Representative, (ii) promptly
file a new registration statement or post-effective amendment, (iii) use its best efforts to cause
such registration statement or post-effective amendment to be declared effective and (iv) promptly
notify the Representative of such effectiveness. The Company will take all other action necessary
or appropriate to permit the public offering and sale of the Securities to continue as contemplated
in the registration statement that was subject to Rule 401(g)(2) notice or for which the Company
has otherwise become ineligible. References herein to the Registration Statement shall include such
new registration statement or post-effective amendment, as the case may be.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and
agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the planning
for use of, any “free writing prospectus”, as defined in Rule 405 under the Securities Act other
than (i) a free writing prospectus that, solely as a result of use by such Underwriter, would not
trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule 433
(other than a free writing prospectus under clause (b)), (ii) any Issuer Free Writing Prospectus
listed on Annex A or prepared pursuant to Section 3(c) or Section 4(c) above, or (iii) any free
writing prospectus prepared by such Underwriter and approved by the Company in advance in writing
(each such free writing prospectus referred to in clauses (i) or (iii), an “Underwriter Free
Writing Prospectus”).
(b) It has not and will not, without the prior written consent of the Company, use any free
writing prospectus that contains the final terms of the Securities unless such terms have
previously been included in a free writing prospectus filed with the Commission; provided that
Underwriters may, at any time, use a term sheet substantially in the form of Annex B hereto without
the consent of the Company; provided further that if such term sheet is different in any
significant respect then any Underwriter using such term sheet shall notify the Company, and
provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the
first use of such term sheet.
(c) It will, pursuant to reasonable procedures developed in good faith, retain copies of each
Underwriter Free Writing Prospectus in accordance with Rule 433 under the Securities Act.
(d) It is not subject to any pending proceeding under Section 8A of the Securities Act with
respect to the offering of the Securities (and will promptly notify the Company if any such
proceeding against it is initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to
purchase Securities on the Closing Date as provided herein is subject to the performance by the
Company of its covenants and other obligations hereunder and to the following additional conditions
precedent:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule
401(g)(2) or pursuant to Section 8A under the Securities Act, shall be pending before or threatened
by the Commission; the Preliminary Prospectus, the Prospectus and each Issuer Free Writing
Prospectus shall have been timely filed with the Commission under the Securities Act (in the case
of a Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act)
and in accordance with Section 4(a) hereof; and all requests by the Commission for additional
information shall have been complied with to the reasonable satisfaction of the Representative.
7
(b) Representations and Warranties. The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing Date;
and the statements of the Company and its officers made in any certificates delivered pursuant to
this Agreement shall be true and correct on and as of the Closing Date.
(c) No Downgrade. Subsequent to the execution and delivery of this Agreement, (i) no
downgrading shall have occurred in the rating accorded the Securities or any other debt securities
or preferred stock of or guaranteed by the Company or any of its subsidiaries by any “nationally
recognized statistical rating organization”, as such term is defined by the Commission for purposes
of Rule 436(g)(2) under the Securities Act and (ii) no such organization shall have publicly
announced that it has under surveillance or review, or has changed its outlook with respect to, its
rating of the Securities or of any other debt securities or preferred stock of or guaranteed by the
Company or any of its subsidiaries (other than an announcement with positive implications of a
possible upgrading).
(d) No Material Adverse Change. (i) No change, or development involving a prospective change,
in or affecting particularly the properties, assets, business, results of operations or condition
(financial or otherwise) of the Company or its subsidiaries shall have occurred or shall exist,
which change or development is not described in the Time of Sale Information (excluding any
amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto)
and the effect of which in the judgment of the Representative makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Securities on the terms and in the manner
contemplated by this Agreement, the Time of Sale Information and the Prospectus; (ii) no suspension
or limitation of trading in securities generally on the New York Stock Exchange, or any setting of
minimum prices or trading on such exchange, or any suspension of trading of any securities of the
Company on any exchange or in the over-the-counter market shall have occurred; (iii) no banking
moratorium declared by Federal or New York authorities or a material disruption in commercial
banking or securities settlement or clearance services shall have occurred; and (iv) no material
adverse change in the financial markets in the United States or in the international financial
markets, or any outbreak or escalation of major hostilities in which the United States is involved,
any declaration of war by Congress or any other substantial national or international calamity or
emergency shall have occurred if, in the judgment of the Representative, the effect of any such
change, outbreak, escalation, declaration, calamity or emergency makes it impractical or
inadvisable to proceed with completion of the sale of and payment for the Securities.
(e) Officer’s Certificate. The Representative shall have received on and as of the Closing
Date a certificate of an executive officer of the Company who has specific knowledge of the
Company’s financial matters and is satisfactory to the Representative (i) confirming that such
officer has carefully reviewed the Registration Statement, the Time of Sale Information and the
Prospectus and, to the best knowledge of such officer, the representations set forth in Sections
3(b) or 3(d) hereof are true and correct, (ii) confirming that the other representations and
warranties of the Company in this Agreement are true and correct and that the Company has complied
with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder
at or prior to the Closing Date and (iii) to the effect set forth in paragraphs (a), (c) and (d)
(i) above.
(f) Comfort Letter. On the date of this Agreement and on the Closing Date, KPMG, LLP shall
have furnished to the Representative, at the request of the Company, a letter, dated the respective
dates of delivery thereof and addressed to the Underwriters, to the effect that:
(i) in their opinion, the financial statements and schedules audited by them and
included or incorporated by reference in the Registration Statement, the Time of Sale
Information or the Prospectus comply in form in all material respects with the applicable
accounting requirements of the Securities Act and the Exchange Act;
(ii) they have performed the procedures specified by the American Institute of
Certified Public Accountants for a review of interim financial information as described in
Statement of Auditing Standards No. 100, Interim Financial Information, on any unaudited
financial statements included or incorporated by reference in the Registration Statement,
the Time of Sale Information or the Prospectus;
(iii) on the basis of the review, if any, referred to in clause (ii) above, a reading
of the latest available interim financial statements of the Company, inquiries of officials
of the Company who have
8
responsibility for financial and accounting matters and other specified procedures,
nothing came to their attention that caused them to believe that:
(A) the unaudited consolidated financial statements, if any, included or
incorporated by reference in the Registration Statement, the Time of Sale
Information or the Prospectus do not comply as to form in all material respects with
the applicable accounting requirements of the Securities Act and the Exchange Act or
any material modification should be made to such unaudited financial statements for
them to be in conformity with generally accepted accounting principles;
(B) the unaudited summary financial information, if any, included or
incorporated by reference in the Registration Statement, the Time of Sale
Information or the Prospectus does not agree with the amounts set forth in the
unaudited consolidated financial statements from which it was derived or was not
determined on a basis substantially consistent with that of the audited financial
statements included or incorporated by reference in the Registration Statement, the
Time of Sale Information or the Prospectus;
(C) at the date of the latest available balance sheet read by such accountants,
there was any change in the capital stock or any increase in long-term debt,
including current maturities, or decrease in net current assets or total
shareholders’ equity of the Company and consolidated subsidiaries, in each case as
compared with amounts shown on the latest balance sheet included or incorporated by
reference in the Registration Statement, the Time of Sale Information or the
Prospectus; and at a subsequent specified date not more than three business days
prior to the Closing Date, there was any change in the capital stock or any increase
in long-term debt, including current maturities, or decrease in net current assets
or total shareholders’ equity of the Company and consolidated subsidiaries as
compared with amounts shown on the latest balance sheet included or incorporated by
reference in the Registration Statement, the Time of Sale Information or the
Prospectus; and
(D) for the period from the date of the latest income statement included or
incorporated by reference in the Registration Statement, the Time of Sale
Information or the Prospectus to the closing date of the latest available income
statements read by such accountants, there were any decreases, as compared with the
corresponding period of the preceding year, in net sales, operating income or total
or per share net income of the Company and consolidated subsidiaries; and for the
period from the closing date of the latest available income statement included or
incorporated by reference in the Registration Statement, the Time of Sale
Information or the Prospectus to a subsequent specified date not more than three
business days prior to the Closing Date, there were any decreases, as compared with
the corresponding period in the preceding year, in net sales, operating income or
total or per share net income of the Company and consolidated subsidiaries; except
in all cases set forth in clauses (C) and (D) above for changes, increases or
decreases which the Registration Statement, the Time of Sale Information and the
Prospectus disclose have occurred or may occur;
(iv) in addition to the procedures specified in clause (ii) above, they have carried
out certain other limited procedures of a nature customarily the subject of independent
auditors’ comfort letters with respect to (A) specified dollar amounts (or percentages
derived from such dollar amounts) and (B) other financial information of a nature
customarily the subject of independent auditors’ comfort letters, which is contained or
incorporated by reference in the Registration Statement, the Time of Sale Information or the
Prospectus, including, without limitation, the ratios of earnings to fixed charges, and have
found such dollar amounts, percentages and other financial information to be in agreement
with the relevant accounting and financial records specified in such letter.
(g) Opinion of Counsel for the Company. ▇▇▇▇▇▇ and ▇▇▇▇▇▇, Professional Association, counsel
for the Company, shall have furnished to the Representative, at the request of the Company, their
written opinion, dated the Closing Date and addressed to the Underwriters, to the effect that:
9
(i) The Company has been duly incorporated and is an existing corporation in good
standing under the laws of the State of Delaware, with corporate power and authority to own,
lease and operate its properties and conduct its business as described in the Prospectus and
the Time of Sale Information; the Company is duly qualified to do business as a foreign
corporation in good standing in the states of Minnesota and Illinois; each “significant
subsidiary” (as defined in Regulation S-X of the Commission) of the Company, i.e.,
P-Americas, Inc. and Pepsi-Cola General Bottlers, Inc., is an existing corporation in good
standing under the laws of the jurisdiction of its incorporation, with corporate power and
authority to own, lease and operate its properties and conduct its business as described in
the Prospectus and the Time of Sale Information. P-Americas, Inc. is duly qualified to do
business as a foreign corporation in good standing in the states of Iowa, Minnesota, North
Dakota and South Dakota. Pepsi-Cola General Bottlers, Inc. is duly qualified to do business
as a foreign corporation in good standing in the states of Indiana, Illinois, Iowa, Kansas,
Kentucky, Minnesota, Missouri, North Dakota, Ohio, Tennessee, and Wisconsin;
(ii) The Securities have been duly authorized by the Company and the terms thereof have
been established in accordance with the Indenture; and when duly executed and authenticated
in accordance with the provisions of the Indenture and delivered to the Underwriters in
accordance with this Agreement against payment of the agreed upon consideration therefor,
the Securities will constitute valid and legally binding obligations of the Company,
entitled to the benefits of the Indenture and enforceable against the Company in accordance
with their terms, subject to (a) bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability relating to or
affecting the enforcement of creditors’ rights and (b) to general principles of equity
(regardless of whether enforceability is considered in a proceeding in equity or at law);
(iii) The Securities and the Indenture conform in all material respects to the
description thereof contained in the Registration Statement, the Time of Sale Information
and the Prospectus;
(iv) The Indenture has been duly authorized, executed and delivered by the Company, has
been duly qualified under the Trust Indenture Act and constitutes a valid and legally
binding obligation of the Company, enforceable against the Company in accordance with its
terms, subject to (a) bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar laws of general applicability relating to or affecting the
enforcement of creditors’ rights, (b) to general principles of equity (regardless of whether
enforceability is considered in a proceeding in equity or at law), (c) any requirement that
a claim with respect to any debt security issued thereunder that is denominated in a
currency other than U.S. dollars (or a judgment denominated in a currency other than U.S.
dollars in respect of such claim) be converted into U.S. dollars at a rate of exchange
prevailing on a date determined in accordance with applicable law and (d) governmental
authority to limit, delay or prohibit the making of payments outside of the United States or
in a foreign currency;
(v) Each document filed pursuant to the Exchange Act and incorporated by reference in
the Time of Sale Information and the Prospectus (or any amendment or supplement thereto
prior to the Closing Date) (other than the financial statements and the notes thereto and
the supporting schedules and other financial or statistical data derived therefrom contained
or incorporated by reference therein, as to which no opinion need be given) complied when
filed, or as subsequently amended, as to form in all material respects with the Exchange
Act;
(vi) No consent, approval, authorization or order of, or filing with, any governmental
agency or body or any court is required by the Company for the consummation of the
transactions contemplated by this Agreement in connection with the issuance or sale of the
Securities by the Company, except such as have been obtained or made under the Securities
Act and the Trust Indenture Act and such as may be required under state securities laws or
Blue Sky laws of various jurisdictions;
(vii) The Registration Statement is an “automatic shelf registration statement” as
defined under Rule 405 of the Securities Act that has been filed with the Commission not
earlier than three years prior to the date of this Agreement; each of the Preliminary
Prospectus and the Prospectus was filed with the Commission pursuant to the subparagraph of
Rule 424(b) under the Securities Act specified in such opinion on the date specified
therein; each Issuer Free Writing Prospectus was filed with the Commission
10
pursuant to the Rule 433 under the Securities Act; and, to the best of such counsel’s
knowledge, no order suspending the effectiveness of the Registration Statement has been
issued, no notice of objection of the Commission to the use of the Registration Statement or
any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has
been received by the Company, and no proceeding for that purpose or pursuant to Section 8A
of the Securities Act against the Company or in connection with the offering is pending or
threatened by the Commission; the Registration Statement, the Preliminary Prospectus, each
Issuer Free Writing Prospectus included in the Time of Sale Information and the Prospectus
(other than the financial statements and the notes thereto and the supporting schedules and
other financial or statistical data derived therefrom contained or incorporated by reference
therein, as to which no opinion need be given) complied when filed, or as subsequently
amended, as to form in all material respects with the Securities Act; and the Indenture
complies as to form in all material respects with the requirements of the Trust Indenture
Act;
(viii) The Company has the power and authority to authorize, issue and sell the
Securities as contemplated by this Agreement; and this Agreement has been duly authorized,
executed and delivered by the Company;
(ix) The execution, delivery and performance of the Indenture and the Underwriting
Agreement, and the issuance and sale of the Securities and compliance with the terms and
provisions thereof, do not (i) violate the Certificate of Incorporation or By-laws of the
Company or any significant subsidiary, (ii) violate any law, statute, rule or regulation
applicable to the Company or any significant subsidiary, (iii) violate any order, writ,
judgment, award, injunction or decree that affects or purports to affect the right of the
Company or any of its subsidiaries to borrow money or to incur any other obligation of the
type evidenced by the Securities, in each case listed in a certificate of an officer of the
Company as applicable to the Company, or (iv) result in a breach or violation of, or
constitute a default under, or result in the creation of a lien upon any property or asset
of the Company or any significant subsidiary pursuant to, any material agreement or
instrument filed or referenced as an exhibit to the Company’s Annual Report on Form 10-K for
the year ended December 29, 2007, or to any report on Form 8-K or Form 10-Q filed since
December 29, 2007;
(x) The Company is not, and upon the issuance and sale of the Securities and the
application of the net proceeds therefrom as described in the Registration Statement, the
Time of Sale Information and the Prospectus will not be, an “investment company” within the
meaning of the Investment Company Act of 1940, as amended;
(xi) To the best of such counsel’s knowledge, except as described in the Registration
Statement, the Time of Sale Information and the Prospectus, there is not pending or
threatened any action, suit, proceeding, inquiry or investigation to which the Company or
any of its subsidiaries thereof is a party or to which the assets, properties or operations
of the Company or any of its subsidiaries thereof is subject, before or by any court or
governmental agency or body, domestic or foreign, which might reasonably be expected to
result in a material adverse change in the properties, assets, business, results of
operations or condition (financial or otherwise) of the Company and its subsidiaries taken
as a whole or which might reasonably be expected to materially and adversely affect the
assets, properties or operations thereof or the consummation of the transactions
contemplated under this Agreement or the performance by the Company of its obligations
thereunder or under the Indenture or the Securities; and
(xii) Nothing has come to such counsel’s attention that causes such counsel to believe
that the Registration Statement, at the time of its effectiveness (including the
information, if any, deemed pursuant to Rule 430B or 430C to be part of the Registration
Statement at the time of effectiveness), contained any untrue statement of a material fact
or omitted to state any material fact required to be stated therein or necessary to make the
statements therein not misleading, that the Time of Sale Information, at the Time of Sale
(which such counsel may assume to be the date of this Agreement), contained any untrue
statement of a material fact or omitted to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading, or that the Prospectus or any amendment or supplement thereto, as of the date of
the Prospectus, as of the date of the Prospectus as amended or supplemented or as of the
Closing Date, contained or contains any untrue statement of a
11
material fact or omitted or omits to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading; and the descriptions in the Registration Statement, the Time of Sale Information
and the Prospectus of statutes, legal and governmental proceedings and contracts and other
documents constitute an accurate summary of such statutes, proceedings, contracts and other
documents in all material respects; it being understood that such counsel need express no
opinion or belief as to the financial statements and the notes thereto, and the supporting
schedules and other financial or statistical data derived therefrom contained or
incorporated by reference in the Registration Statement, the Time of Sale Information or the
Prospectus.
(h) Opinion of Counsel for the Underwriters. The Representative shall have received on and as
of the Closing Date an opinion of ▇▇▇▇▇ ▇▇▇▇▇ LLP, counsel for the Underwriters, with respect to
such matters as the Representative may reasonably request, and such counsel shall have received
such documents and information as they may reasonably request to enable them to pass upon such
matters.
The Company will furnish the Representatives with such additional copies of such opinions,
certificates, letters and documents as they reasonably request.
7. Indemnification and Contribution.
(a) Indemnification of Underwriters. The Company agrees to indemnify and hold harmless each
Underwriter against any losses, claims, damages or liabilities, joint or several, to which such
Underwriter may become subject, under the Securities Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any
untrue statement or alleged untrue statement of any material fact contained in the Registration
Statement, any Preliminary Prospectus, the Prospectus, any Issuer Free Writing Prospectus or the
Time of Sale Information or, in each case, any amendment or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material fact necessary in order
to make the statements therein, in light of the circumstances under which they were made except in
the case of the Registration Statement, not misleading, and will reimburse each Underwriter for any
legal or other expense reasonably incurred by such Underwriter in connection with investigating or
defending any such loss, claim, damage, liability or action as such expenses are incurred;
provided, however, that the Company will not be liable in any such case to the extent that any such
loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged
untrue statement in or omission or alleged omission from any of such documents in reliance upon and
in conformity with written information furnished to the Company by any Underwriter through the
Representative, if any, specifically for use therein.
(b) Indemnification of the Company. Each Underwriter severally agrees to indemnify and hold
harmless the Company against any losses, claims, damages or liabilities to which the Company may
become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or
liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or
alleged untrue statement of any material fact contained in the Registration Statement, the
Preliminary Prospectus, the Prospectus (or any amendment or supplement thereto), or any Issuer Free
Writing Prospectus, or arise out of or are based upon the omission or the alleged omission to state
therein a material fact necessary in order to make the statements therein, in light of the
circumstances under which they were made except in the case of the Registration Statement, not
misleading, in each case to the extent, but only to the extent, that such untrue statement or
alleged untrue statement or omission or alleged omission was made in reliance upon and in
conformity with written information furnished to the Company by such Underwriter through the
Representative, if any, specifically for use therein, and will reimburse the Company for any legal
or other expenses reasonably incurred by the Company in connection with investigating or defending
any such loss, claim, damage, liability or action as such expenses are incurred.
(c) Notice and Procedure. Promptly after receipt by an indemnified party under this Section 7
of notice of the commencement of any action, such indemnified party will, if a claim in respect
thereof is to be made against the indemnifying party under subsection (a) or (b) above, notify the
indemnifying party of the commencement thereof, but the omission so to notify the indemnifying
party will not relieve it from any liability which it may have to any indemnified party otherwise
than under subsection (a) or (b) above. In the case of parties indemnified pursuant to subsection
(a) above, counsel to the indemnified parties shall be selected by the Representative and, in the
case of parties indemnified pursuant to subsection (b) above, counsel to the indemnified
12
parties shall be selected by the Company. An indemnifying party will be entitled to
participate in the defense of any such action; provided, however, that counsel to the indemnifying
party shall not, except with the consent of the indemnified party, also be counsel to the
indemnifying party. In no event shall the indemnifying party be liable to such indemnified party
under this Section 7 for the fees and expenses of more than one counsel (in addition to local
counsel) separate from its own counsel for all indemnified parties in connection with any one
action or separate but similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances.
(d) Contribution and Limitation on Liability. If the indemnification provided for in this
Section 7 is unavailable or insufficient to hold harmless an indemnified party under subsection (a)
or (b) above, then each indemnifying party shall contribute to the amount paid or payable by such
indemnified party as a result of the losses, claims, damages or liabilities referred to in
subsection (a) or (b) above (i) in such proportion as is appropriate to reflect the relative
benefits received by the Company on the one hand and the Underwriters on the other from the
offering of the Securities or (ii) if the allocation provided by clause (i) above is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i) above but also the relative fault of the Company on the one hand and the
Underwriters on the other in connection with the statements or omissions which resulted in such
losses, claims, damages or liabilities as well as any other relevant equitable considerations. The
relative benefits received by the Company on the one hand and the Underwriters on the other shall
be deemed to be in the same proportion as the total net proceeds from the offering (before
deducting expenses) received by the Company bear to the total underwriting discounts and
commissions received by the Underwriters. The relative fault shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the
Company or the Underwriters and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such untrue statement or omission. The Company and the
Underwriters agree that it would not be just and equitable if contribution pursuant to this
subsection (d) were determined by pro rata allocation (even if the Underwriters were treated as one
entity) or by any other method of allocation that does not take into account the equitable
considerations referred to in this subsection (d). The amount paid by an indemnified party as a
result of the losses, claims, damages or liabilities referred to in the first sentence of this
subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any action or claim which is the
subject of this subsection (d). Notwithstanding the provisions of this subsection (d), no
Underwriter shall be required to contribute any amount in excess of the amount by which the total
price at which the Securities underwritten by it and distributed to the public were offered to the
public exceeds the amount of any damages which such Underwriter has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations in this subsection (d) to contribute are several
in proportion to their respective underwriting obligations and not joint.
(e) Non-Exclusive Remedies. The obligations of the Company under this Section 7 shall be in
addition to any liability which the Company may otherwise have and shall extend, upon the same
terms and conditions, to each person, if any, who controls any Underwriter within the meaning of
the Securities Act; and the obligations of the Underwriters under this Section shall be in addition
to any liability which the respective Underwriters may otherwise have and shall extend, upon the
same terms and conditions, to each director of the Company, to each officer of the Company who has
signed the Registration Statement and to each person, if any, who controls the Company within the
meaning of the Securities Act.
8. Default of Underwriters. If any Underwriter defaults or Underwriters default in
their obligations to purchase Securities hereunder and the aggregate principal amount of the
Securities that such defaulting Underwriter or Underwriters agreed but failed to purchase does not
exceed 10% of the total principal amount of the Securities, the Representative may make
arrangements satisfactory to the Company for the purchase of such Securities by other persons,
including any of the Underwriters, but if no such arrangements are made by the Closing Date, the
non-defaulting Underwriters shall be obligated severally, in proportion to their respective
commitments hereunder, to purchase the Securities that such defaulting Underwriters agreed but
failed to purchase. If any Underwriter defaults or Underwriters default and the aggregate principal
amount of the Securities with respect to which such default or defaults occur exceeds 10% of the
total principal amount of the Securities and arrangements satisfactory to the Representative and
the Company for the purchase of such Securities by other persons are not made within 36 hours after
such default, this Agreement will terminate without liability on the part of any nondefaulting
Underwriter or
13
the Company, except as provided in Section 4(h). As used in this Agreement, the term
“Underwriter” includes any person substituted for an Underwriter under this Section. Nothing herein
will relieve a defaulting Underwriter from liability for its default.
9. Survival of Certain Representations and Obligations. The respective indemnities,
agreements, representations, warranties and other statements of the Company or its officers and of
the several Underwriters set forth in or made pursuant to this Agreement will remain in full force
and effect, regardless of any investigation, or statement as to the results thereof, made by or on
behalf of any Underwriter, the Company or any of their respective representatives, officers or
directors or any controlling person and will survive delivery of and payment for the Securities. If
for any reason the purchase of the Securities by the Underwriters hereunder is not consummated, the
Company shall remain responsible for the expenses to be paid or reimbursed by it pursuant to
Section 4 and the respective obligations of the Company and the Underwriters pursuant to Section 7
shall remain in effect. If the purchase of the Securities by the Underwriters is not consummated
for any reason other than solely because of the termination of this Agreement pursuant to Section 8
or the occurrence of any event specified in clause (ii) (other than with respect to the Company’s
securities), (iii) or (iv) of Section 6(d), the Company will reimburse the Underwriters for all
out-of-pocket expenses (including fees and disbursements of counsel) reasonably incurred by them in
connection with the offering of the Securities.
10. Notices. All communications hereunder will be in writing and, if sent to the
Underwriters, will be mailed, delivered or telegraphed and confirmed to the Representatives at Banc
of America Securities LLC, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇-▇▇▇-▇▇-▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention:
High Grade Debt Capital Markets Transaction Management/Legal, facsimile no. (▇▇▇) ▇▇▇-▇▇▇▇ and to
▇.▇. ▇▇▇▇▇▇ Securities Inc., ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇, Attention: High Grade
Syndicate Desk, facsimile no. (▇▇▇) ▇▇▇-▇▇▇▇ or, if sent to the Company, will be mailed, delivered
or telegraphed and confirmed to it at PepsiAmericas, Inc., 4000 ▇▇▇▇ ▇▇▇▇▇▇▇▇ Plaza, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Attention: Secretary.
11. Successors. This Agreement will inure to the benefit of and be binding upon the
Company and such Underwriters as are identified in Schedule 1 hereto and their respective
successors and the officers and directors and controlling persons referred to in Section 7, and no
other person will have any right or obligation hereunder.
12. Applicable Law. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of New York.
14
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
| Very truly yours, PEPSIAMERICAS, INC. |
||||
| By: | /s/ ▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇ | |||
| Name: | ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ | |||
| Title: | Executive Vice President and Chief Financial Officer |
|||
Accepted: February 9, ▇▇▇▇
▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇ Securities LLC
| By: | /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |||
| Name: | ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |||
| Title: | Vice President | |||
▇.▇. ▇▇▇▇▇▇ Securities Inc.
| By: | /s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ | |||
| Name: | ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ | |||
| Title: | Vice President | |||
For themselves and on behalf of the
several Underwriters listed
in Schedule 1 hereto. |
15
Schedule 1
| Underwriter | Principal Amount | |||
Banc of America Securities LLC |
$ | 105,000,000 | ||
▇.▇. ▇▇▇▇▇▇ Securities Inc. |
105,000,000 | |||
Wachovia Capital Markets, LLC |
35,000,000 | |||
BNP Paribas Securities Corp. |
25,000,000 | |||
Citigroup Global Markets Inc. |
25,000,000 | |||
▇▇▇▇▇▇▇, ▇▇▇▇▇ & Co. |
25,000,000 | |||
▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co. Incorporated |
25,000,000 | |||
Loop Capital Markets, LLC |
5,000,000 | |||
Total |
$ | 350,000,000 | ||
16
Annex A
| a. | Time of Sale Information | |
| (1) | Pricing Term Sheet relating to the Securities (copy attached) |
17
Pricing Term Sheet
PepsiAmericas, Inc.
$350,000,000 4.375% Notes due 2014
Issuer: |
PepsiAmericas, Inc. | |
Ratings: |
Baa1 / A / A | |
Size: |
$350,000,000 | |
Trade Date: |
February 9, 2009 | |
Settlement Date: |
February 12, 2009 | |
Maturity: |
February 15, 2014 | |
Optional Redemption: |
Make Whole at T+40 basis points | |
Benchmark: |
1.75% due January 31, 2014 | |
Benchmark Treasury Yield: |
2.017% | |
Re-offer Spread: |
+250 bps | |
Public Offering Yield: |
4.517% | |
Coupon: |
4.375% | |
Interest Payment Dates: |
February 15 and August 15, commencing August | |
| 15, 2009 | ||
Public Offering Price: |
99.369% | |
CUSIP Number: |
▇▇▇▇▇▇▇▇▇ | |
Joint Bookrunning Managers: |
Banc of America Securities LLC | |
| ▇.▇. ▇▇▇▇▇▇ Securities Inc. | ||
Co-Managers: |
Wachovia Capital Markets, LLC | |
| BNP Paribas Securities Corp. | ||
| Citigroup Global Markets Inc. | ||
| ▇▇▇▇▇▇▇, ▇▇▇▇▇ & Co. | ||
| ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co. Incorporated | ||
| Loop Capital Markets, LLC |
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be
subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus,
any related prospectus supplement, and other documents the issuer has filed with the SEC for more
complete information about the issuer and this offering. You may get these documents for free by
visiting ▇▇▇▇▇ on the SEC Web site at ▇▇▇.▇▇▇.▇▇▇. Alternatively, the issuer, any underwriter or
any dealer participating in the offering will arrange to send you the prospectus if you request it
by calling Banc of America Securities LLC toll free or e-mailing at 1-800-294-1322 or
▇▇.▇▇▇▇▇▇▇▇▇▇_▇▇▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ or calling ▇.▇. ▇▇▇▇▇▇ Securities Inc. at (▇▇▇)
▇▇▇-▇▇▇▇
18
Annex B
Pricing Term Sheet
PepsiAmericas, Inc.
$350,000,000 4.375% Notes due 2014
Issuer: |
PepsiAmericas, Inc. | |
Ratings: |
Baa1 / A / A | |
Size: |
$350,000,000 | |
Trade Date: |
February 9, 2009 | |
Settlement Date: |
February 12, 2009 | |
Maturity: |
February 15, 2014 | |
Optional Redemption: |
Make Whole at T+40 basis points | |
Benchmark: |
1.75% due January 31, 2014 | |
Benchmark Treasury Yield: |
2.017% | |
Re-offer Spread: |
+250 bps | |
Public Offering Yield: |
4.517% | |
Coupon: |
4.375% | |
Interest Payment Dates: |
February 15 and August 15, commencing August | |
| 15, 2009 | ||
Public Offering Price: |
99.369% | |
CUSIP Number: |
▇▇▇▇▇▇▇▇▇ | |
Joint Bookrunning Managers: |
Banc of America Securities LLC | |
| ▇.▇. ▇▇▇▇▇▇ Securities Inc. | ||
Co-Managers: |
Wachovia Capital Markets, LLC | |
| BNP Paribas Securities Corp. | ||
| Citigroup Global Markets Inc. | ||
| ▇▇▇▇▇▇▇, ▇▇▇▇▇ & Co. | ||
| ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & Co. Incorporated | ||
| Loop Capital Markets, LLC |
Note: A securities rating is not a recommendation to buy, sell or hold securities and may be
subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus,
any related prospectus supplement, and other documents the issuer has filed with the SEC for more
complete information about the issuer and this offering. You may get these documents for free by
visiting ▇▇▇▇▇ on the SEC Web site at ▇▇▇.▇▇▇.▇▇▇. Alternatively, the issuer, any underwriter or
any dealer participating in the offering will arrange to send you the prospectus if you request it
by calling Banc of America Securities LLC toll free or e-mailing at 1-800-294-1322 or
▇▇.▇▇▇▇▇▇▇▇▇▇_▇▇▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ or calling ▇.▇. ▇▇▇▇▇▇ Securities Inc. at (▇▇▇)
▇▇▇-▇▇▇▇
19